PDS Biotechnology Corporation announced the appointment of Seth Van Voorhees, Ph.D. as its new Chief Financial Officer effective January 1, 2021. Dr. Van Voorhees most recently served as the CFO of Research Frontiers and for American Pacific. Earlier in his career, he was an investment banking officer responsible for chemical/pharmaceutical clients at Merrill Lynch, UBS Warburg, and Wasserstein Perella. His background includes a Ph.D. in chemistry from the University of Pennsylvania and an MBA in finance from Columbia University.